Biophysics: for HTS hit validation, chemical lead optimization, and beyond
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - July 6, 2017 Category: Drugs & Pharmacology Authors: Christine C. Genick S. Kirk Wright Source Type: research

Using zebrafish as a model to study the role of epigenetics in hearing loss
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - July 6, 2017 Category: Drugs & Pharmacology Authors: Yingzi He Beier Bao Huawei Li Source Type: research

Biophysics: for HTS hit validation, chemical lead optimization, and beyond
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - July 6, 2017 Category: Drugs & Pharmacology Authors: Christine C. Genick S. Kirk Wright Source Type: research

Using zebrafish as a model to study the role of epigenetics in hearing loss
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - July 6, 2017 Category: Drugs & Pharmacology Authors: Yingzi He Beier Bao Huawei Li Source Type: research

The latest advances in the discovery of nitric oxide hybrid drug compounds
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - June 30, 2017 Category: Drugs & Pharmacology Authors: Ricardo A. M. Serafim Filipe G. Pernichelle Elizabeth I. Ferreira Source Type: research

Lipophilicity and biomimetic properties to support drug discovery
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - June 28, 2017 Category: Drugs & Pharmacology Authors: Fotios Tsopelas Constantinos Giaginis Anna Tsantili-Kakoulidou Source Type: research

Erratum
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - June 26, 2017 Category: Drugs & Pharmacology Source Type: research

Accelerating drug development for neuroblastoma - New Drug Development Strategy: an Innovative Therapies for Children with Cancer, European Network for Cancer Research in Children and Adolescents and International Society of Paediatric Oncology Europe Neuroblastoma project
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - June 26, 2017 Category: Drugs & Pharmacology Authors: Lucas Moreno Hubert Caron Birgit Geoerger Angelika Eggert Gudrun Schleiermacher Penelope Brock Dominique Valteau-Couanet Louis Chesler Johannes H Schulte Katleen De Preter Jan Molenaar Alexander Schramm Martin Eilers Tom Van Maerken John Inge Johnsen Mich Source Type: research

Erratum
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - June 26, 2017 Category: Drugs & Pharmacology Source Type: research

Accelerating drug development for neuroblastoma - New Drug Development Strategy: an Innovative Therapies for Children with Cancer, European Network for Cancer Research in Children and Adolescents and International Society of Paediatric Oncology Europe Neuroblastoma project
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - June 26, 2017 Category: Drugs & Pharmacology Authors: Lucas Moreno Hubert Caron Birgit Geoerger Angelika Eggert Gudrun Schleiermacher Penelope Brock Dominique Valteau-Couanet Louis Chesler Johannes H Schulte Katleen De Preter Jan Molenaar Alexander Schramm Martin Eilers Tom Van Maerken John Inge Johnsen Mich Source Type: research

The discovery and development of romidepsin for the treatment of T-cell lymphoma
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - June 22, 2017 Category: Drugs & Pharmacology Authors: Piotr Smolewski Tadeusz Robak Source Type: research

Current mathematical models for cancer drug discovery
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - June 22, 2017 Category: Drugs & Pharmacology Authors: Letizia Carrara Silvia Maria Lavezzi Elisa Borella Giuseppe De Nicolao Paolo Magni Italo Poggesi Source Type: research

The discovery and development of romidepsin for the treatment of T-cell lymphoma
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - June 22, 2017 Category: Drugs & Pharmacology Authors: Piotr Smolewski Tadeusz Robak Source Type: research

Current mathematical models for cancer drug discovery
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - June 22, 2017 Category: Drugs & Pharmacology Authors: Letizia Carrara Silvia Maria Lavezzi Elisa Borella Giuseppe De Nicolao Paolo Magni Italo Poggesi Source Type: research

An omics perspective to the molecular mechanisms of anticancer metallo-drugs in the computational microscope era
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - June 21, 2017 Category: Drugs & Pharmacology Authors: Angelo Spinello Alessandra Magistrato Source Type: research

Using ChEMBL web services for building applications and data processing workflows relevant to drug discovery
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - June 12, 2017 Category: Drugs & Pharmacology Authors: Micha ł M. Nowotka Anna Gaulton David Mendez A. Patricia Bento Anne Hersey Andrew Leach Source Type: research

Future drug discovery in renin-angiotensin-aldosterone system intervention
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - June 9, 2017 Category: Drugs & Pharmacology Authors: Maria Tamargo Juan Tamargo Source Type: research

The advancement of multidimensional QSAR for novel drug discovery - where are we headed?
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - June 8, 2017 Category: Drugs & Pharmacology Authors: Tao Wang Xin-song Yuan Mian-Bin Wu Jian-Ping Lin Li-Rong Yang Source Type: research

Learning from the failures of drug discovery in B-cell non-Hodgkin lymphomas and perspectives for the future: chronic lymphocytic leukemia and diffuse large B-cell lymphoma as two ends of a spectrum in drug development
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - June 7, 2017 Category: Drugs & Pharmacology Authors: Boris Kubuschok Martin Trepel Source Type: research

Novel approaches to develop community-built biological network models for potential drug discovery
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - June 6, 2017 Category: Drugs & Pharmacology Authors: Marja Talikka Natalia Bukharov William S. Hayes Martin Hofmann-Apitius Leonidas Alexopoulos Manuel C. Peitsch Julia Hoeng Source Type: research

Rational design strategies for FimH antagonists: new drugs on the horizon for urinary tract infection and Crohn ’s disease
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - June 2, 2017 Category: Drugs & Pharmacology Authors: Laurel K. Mydock-McGrane Thomas J. Hannan James W. Janetka Source Type: research

New routes in frontotemporal dementia drug discovery
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - June 2, 2017 Category: Drugs & Pharmacology Authors: Laura De Conti Barbara Borroni Marco Baralle Source Type: research

Rational design strategies for FimH antagonists: new drugs on the horizon for urinary tract infection and Crohn ’s disease
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - June 2, 2017 Category: Drugs & Pharmacology Authors: Laurel K. Mydock-McGrane Thomas J. Hannan James W. Janetka Source Type: research

New routes in frontotemporal dementia drug discovery
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - June 2, 2017 Category: Drugs & Pharmacology Authors: Laura De Conti Barbara Borroni Marco Baralle Source Type: research

The preclinical discovery of vosaroxin for the treatment of acute myeloid leukemia
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - May 23, 2017 Category: Drugs & Pharmacology Authors: Etienne Paubelle Florence Zylbersztejn Xavier Thomas Source Type: research

Understanding sleep-wake mechanisms and drug discovery
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - May 23, 2017 Category: Drugs & Pharmacology Authors: Ana Clementina Equihua-Ben ítez Khalil Guzm án-Vásquez Ren é Drucker-Colín Source Type: research

Harnessing public domain data to discover and validate therapeutic targets
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - May 23, 2017 Category: Drugs & Pharmacology Authors: William C. Reisdorf Neha Chhugani Philippe Sanseau Pankaj Agarwal Source Type: research

The preclinical discovery of vosaroxin for the treatment of acute myeloid leukemia
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - May 23, 2017 Category: Drugs & Pharmacology Authors: Etienne Paubelle Florence Zylbersztejn Xavier Thomas Source Type: research

Understanding sleep-wake mechanisms and drug discovery
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - May 23, 2017 Category: Drugs & Pharmacology Authors: Ana Clementina Equihua-Ben ítez Khalil Guzm án-Vásquez Ren é Drucker-Colín Source Type: research

Harnessing public domain data to discover and validate therapeutic targets
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - May 23, 2017 Category: Drugs & Pharmacology Authors: William C. Reisdorf Neha Chhugani Philippe Sanseau Pankaj Agarwal Source Type: research

The impact of genetics on future drug discovery in schizophrenia
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - May 19, 2017 Category: Drugs & Pharmacology Authors: Mitsuyuki Matsumoto Noah M. Walton Hiroshi Yamada Yuji Kondo Gerard J. Marek Katsunori Tajinda Source Type: research

Corrigendum
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - May 17, 2017 Category: Drugs & Pharmacology Source Type: research

Combating mutations in genetic disease and drug resistance: understanding molecular mechanisms to guide drug design
Volume 12, Issue 6, June 2017, Page 553-563 . (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - May 11, 2017 Category: Drugs & Pharmacology Authors: Amanda T.S. Albanaz Carlos H.M. Rodrigues Douglas E.V. Pires David B. Ascher Source Type: research

Nonhuman primates as models for the discovery and development of radiation countermeasures
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - May 5, 2017 Category: Drugs & Pharmacology Authors: Vijay K. Singh Ayodele O. Olabisi Source Type: research

Discovery and preclinical development of dasabuvir for the treatment of hepatitis C infection
Volume 12, Issue 6, June 2017, Page 635-642 . (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - May 5, 2017 Category: Drugs & Pharmacology Authors: Mohamed El Kassas Tamer Elbaz Enas Hafez Mohamed Naguib Wifi Gamal Esmat Source Type: research

Nonhuman primates as models for the discovery and development of radiation countermeasures
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - May 5, 2017 Category: Drugs & Pharmacology Authors: Vijay K. Singh Ayodele O. Olabisi Source Type: research

Discovery and preclinical development of dasabuvir for the treatment of hepatitis C infection
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - May 5, 2017 Category: Drugs & Pharmacology Authors: Mohamed El Kassas Tamer Elbaz Enas Hafez Mohamed Naguib Wifi Gamal Esmat Source Type: research